Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

142
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
142
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.9K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.9K
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

15.3K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
15.3K
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

1.9K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
1.9K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

454
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
454
Infertility in Males01:23

Infertility in Males

485
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
485

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interobserver Agreement of Filling Cystometry Parameters in Children With Neurogenic Lower Urinary Tract Dysfunction.

International neurourology journal·2026
Same author

Urinary Incontinence and Psychological Distress Among Parents of Children With Spina Bifida.

Neurourology and urodynamics·2026
Same author

Clinical relevance of postoperative biomarkers in pediatric endourology: Is procalcitonin telling the truth?

Journal of pediatric surgery·2026
Same author

Evaluation of spot urine CA 19 - 9/creatinine ratio in diagnosis and management of hydronephrosis in children: a prospective study.

BMC pediatrics·2025
Same author

Efficiency and Diagnostic Utility of CO<sub>2</sub> Cystoscopy After Laparoscopic Gynecologic Surgery.

JSLS : Journal of the Society of Laparoendoscopic Surgeons·2025
Same author

The Role of Urinary ATP in the Diagnosis, Treatment, and Follow-up of Children With Overactive Bladder.

Neurourology and urodynamics·2025

Related Experiment Videos

Testosterone replacement therapy: should it be performed in erectile dysfunction?

Orcun Celik1, Selcuk Yücel2

  • 1Clinic of Urology, Kemalpasa State Hospital, Kemalpasa, Izmir, Turkey.

Nephro-Urology Monthly
|December 19, 2013
PubMed
Summary

Erectile dysfunction (ED) is complex, often linked to cardiovascular issues, diabetes, and obesity. Combining PDE-5 inhibitors with testosterone replacement may improve treatment for hypogonadal men.

Keywords:
Erectile DysfunctionTestosteroneTherapeutics

Related Experiment Videos

Area of Science:

  • Urology
  • Endocrinology
  • Cardiology

Background:

  • Erectile dysfunction (ED) has multifactorial causes including aging, vascular, neurogenic, psychological, and hormonal factors.
  • ED can precede serious cardiovascular events and is frequently associated with diabetic or obese patients experiencing neuropathy and microvascular damage.
  • A significant subset of patients with ED, particularly those with diabetes and obesity, are unresponsive to phosphodiesterase type 5 (PDE-5) inhibitors.

Purpose of the Study:

  • To explore the complex etiology of erectile dysfunction.
  • To investigate the role of testosterone in PDE-5 expression and its impact on erectile function and libido.
  • To evaluate the potential of combination therapy for ED management in hypogonadal patients.

Main Methods:

  • Review of classical and recent studies on erectile dysfunction etiology.
  • Analysis of the relationship between testosterone, PDE-5 expression, and erectile function.
  • Evaluation of therapeutic strategies for erectile dysfunction.

Main Results:

  • Testosterone influences PDE-5 expression, supporting its role in erection regulation and libido.
  • ED is often linked to underlying conditions like diabetes, obesity, and cardiovascular disease.
  • Hypogonadal patients with ED may not respond optimally to PDE-5 inhibitors alone.

Conclusions:

  • Testosterone replacement therapy alongside PDE-5 inhibitors presents a promising therapeutic approach for hypogonadal patients with erectile dysfunction.
  • Understanding the interplay between hormonal status and PDE-5 inhibition is crucial for effective ED management.
  • Combination therapy may offer a superior alternative for managing complex ED cases, especially in patients with comorbidities.